# LACOSAMIDE

NDC: 31722-203
Generic name: LACOSAMIDE
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220914

FDA application: ANDA216335

## Active ingredients

- LACOSAMIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-203"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-203
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e24d3c45-a559-4fca-a7be-74ce37a7066e